Ginsenoside Rg2
- CAS No.
- 52286-74-5
- Chemical Name:
- Ginsenoside Rg2
- Synonyms
- CHIKUSETSUSAPONIN I;anaxatriol;GinsesideRg2;Panaxoside Rg2;product/154570;PROSAPOGENIN C2;GINSENOSIDE RG2;Ginsenosdie Rg2;mannopyranosyl)-;iGInsenoside Rg2
- CBNumber:
- CB1483174
- Molecular Formula:
- C42H72O13
- Molecular Weight:
- 785.03
- MOL File:
- 52286-74-5.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/6/8 9:02:15
| Melting point | 187～189℃ |
|---|---|
| Boiling point | 881.0±65.0 °C(Predicted) |
| Density | 1.30±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Methanol (Slightly, Heated, Sonicated), Pyridine (Slightly, Sonicated) |
| pka | 12.85±0.70(Predicted) |
| form | Solid |
| color | White to Off-White |
| Stability | Hygroscopic |
| InChIKey | AGBCLJAHARWNLA-DJZXLMSJSA-N |
| LogP | 6.830 (est) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302 | |||||||||
| Precautionary statements | P301+P312+P330 | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 22 | |||||||||
| Safety Statements | 24/25 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | LZ6430000 | |||||||||
| HS Code | 29389090 | |||||||||
| Toxicity | mouse,LD50,intraperitoneal,1340mg/kg (1340mg/kg),Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 343, 1975. | |||||||||
| NFPA 704 |
|
Ginsenoside Rg2 Chemical Properties,Uses,Production
Description
Ginsenosides are pharmacologically active natural compounds from ginseng and other plants of the genus Panax. Structurally, they are steroid glycosides derived from the triterpene squalene. Ginsenoside Rg2 is a protopanaxatriol that is more abundant in some Panax species (e.g., white and red P. ginseng) than others. This ginsenoside and its metabolites have diverse in vitro and in vivo effects, including neuroprotective, anti-
Chemical Properties
White solid
Uses
20(S)-Ginsenoside Rg2 is used as an aldose reductase inhibitor and my exert anti-inflammatory and immunomodulatory activity. It exists as a bioactive metabolite of the ginsenoside component of Panax ginseng.
Ginsenoside Rg2 Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 234)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29900 | 58 | Inquiry |
| Chengdu Biopurify Phytochemicals Ltd. | +8618080483897 | China | 3424 | 58 | Inquiry |
| BOC Sciences | +1-631-485-4226 | United States | 19553 | 58 | Inquiry |
| Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | China | 39916 | 58 | Inquiry |
| Neostar United (Changzhou) Industrial Co., Ltd. | +86-519-519-85557386 | China | 12330 | 58 | Inquiry |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | United States | 19892 | 58 | Inquiry |
| Hubei Ipure Biology Co., Ltd | +8613367258412 | China | 10326 | 58 | Inquiry |
| Hefei TNJ Chemical Industry Co.,Ltd. | 0551-65418671 | China | 34571 | 58 | Inquiry |
| Apeloa Pharmaceutical Co., Ltd. | +86-0571-87635730 +8615858229168 | China | 1478 | 58 | Inquiry |
52286-74-5(Ginsenoside Rg2)Related Search:
anaxatriol
beta-d-glucopyranoside,(3-beta,6-alpha,12-beta)-3,12,20-trihydroxydammar-24-en
mannopyranosyl)-
trihydroxydammar-24-en-6-yl2-O-(6-deoxy-α-L-
β-D-Glucopyranoside,(3β,6α,12β)-3,12,20-
Ginsenoside 20(s)-Rg2
(20S)-Ginsenoside Rg2
[3β,12β,20-Trihydroxy-5α-dammar-24-en-6α-yl]2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
[3β,12β,20-Trihydroxydammar-24-en-6α-yl]2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
6α-(2-O-α-L-Rhamnopyranosyl-β-D-glucopyranosyloxy)-dammara-24-ene-3β,12β,20-triol
GINSENOSIDE Rg2(SH)
Ginsenoside Rg2 ,98%
GinsesideRg2
iGInsenoside Rg2
PROSAPOGENIN C2
GINSENOSIDE RG2
CHIKUSETSUSAPONIN I, PROSAPOGENIN C2
(6)-(alpha-l-rhamnopyranosyl(1-rham-2-glu)-beta-d-glucopyranosyl)-20s-protop
-6-yl-2-o-(6-deoxy-alpha-l-mannopyranosyl)-
(3β,6α,12β)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
b-D-Glucopyranoside, (3b,6a,12b)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-
Ginsenosdie Rg2
Ginsenoside Rg2 (Chikusetsusaponin I
Panaxoside Rg2
product/154570
β-D-Glucopyranoside, (3β,6α,12β)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-
(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
CHIKUSETSUSAPONIN I
(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
GINSENOSIDE Rg2 (S-FORM)
52286-74-5
55086-74-5
55286-74-5
C42H72O13
C40H68O14
Inhibitors
pharmaceutical intermediate
phytochemical
reference standards from Chinese medicinal herbs (TCM).
standardized herbal extract
Saponins
chemical reagent
Ginsenoside series